Russ B Altman
Cited by
Cited by
Missing value estimation methods for DNA microarrays
O Troyanskaya, M Cantor, G Sherlock, P Brown, T Hastie, R Tibshirani, ...
Bioinformatics 17 (6), 520-525, 2001
On the opportunities and risks of foundation models
R Bommasani, DA Hudson, E Adeli, R Altman, S Arora, S von Arx, ...
arXiv preprint arXiv:2108.07258, 2021
Pharmacogenomics knowledge for personalized medicine
M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ...
Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012
Doxorubicin pathways: pharmacodynamics and adverse effects
CF Thorn, C Oshiro, S Marsh, T Hernandez-Boussard, H McLeod, ...
Pharmacogenetics and genomics 21 (7), 440-446, 2011
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
Diversity of gene expression in adenocarcinoma of the lung
ME Garber, OG Troyanskaya, K Schluens, S Petersen, Z Thaesler, ...
Proceedings of the National Academy of Sciences 98 (24), 13784-13789, 2001
Guidelines for investigating causality of sequence variants in human disease
DG MacArthur, TA Manolio, DP Dimmock, HL Rehm, J Shendure, ...
Nature 508 (7497), 469-476, 2014
Personal omics profiling reveals dynamic molecular and medical phenotypes
R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...
Cell 148 (6), 1293-1307, 2012
Principal components analysis to summarize microarray experiments: application to sporulation time series
S Raychaudhuri, JM Stuart, RB Altman
Biocomputing 2000, 455-466, 1999
The chemical genomic portrait of yeast: uncovering a phenotype for all genes
ME Hillenmeyer, E Fung, J Wildenhain, SE Pierce, S Hoon, W Lee, ...
Science 320 (5874), 362-365, 2008
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
KH Yu, C Zhang, GJ Berry, RB Altman, C Ré, DL Rubin, M Snyder
Nature communications 7 (1), 12474, 2016
Machine learning in chemoinformatics and drug discovery
YC Lo, SE Rensi, W Torng, RB Altman
Drug discovery today 23 (8), 1538-1546, 2018
Data-driven prediction of drug effects and interactions
NP Tatonetti, PP Ye, R Daneshjou, RB Altman
Science translational medicine 4 (125), 125ra31-125ra31, 2012
Clinical assessment incorporating a personal genome
EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...
The Lancet 375 (9725), 1525-1535, 2010
A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae)
OG Troyanskaya, K Dolinski, AB Owen, RB Altman, D Botstein
Proceedings of the National Academy of Sciences 100 (14), 8348-8353, 2003
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
Method for monitoring and/or modifying web browsing sessions
RM Felciano, RB Altman
US Patent 6,052,730, 2000
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ...
Nature medicine 22 (5), 547-556, 2016
Metformin pathways: pharmacokinetics and pharmacodynamics
L Gong, S Goswami, KM Giacomini, RB Altman, TE Klein
Pharmacogenetics and genomics 22 (11), 820-827, 2012
Structural bioinformatics
J Gu, PE Bourne
John Wiley & Sons, 2009
The system can't perform the operation now. Try again later.
Articles 1–20